<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:04:32Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5410168" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5410168</identifier><datestamp>2017-10-19</datestamp><setSpec>wtpa</setSpec><setSpec>pmc-open</setSpec><setSpec>manuscript</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5410168</article-id>
      <article-id pub-id-type="pmcid">PMC5410168</article-id>
      <article-id pub-id-type="pmc-uid">5410168</article-id>
      <article-id pub-id-type="pmid">28424515</article-id>
      <article-id pub-id-type="pmid">28424515</article-id>
      <article-id pub-id-type="doi">10.1038/nature22064</article-id>
      <article-id pub-id-type="manuscript">ems71849</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure and allosteric inhibition of excitatory amino acid
transporter 1</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Canul-Tec</surname>
            <given-names>Juan C.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Assal</surname>
            <given-names>Reda</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cirri</surname>
            <given-names>Erica</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Legrand</surname>
            <given-names>Pierre</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brier</surname>
            <given-names>SÃ©bastien</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chamot-Rooke</surname>
            <given-names>Julia</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reyes</surname>
            <given-names>Nicolas</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref ref-type="corresp" rid="CR1">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Molecular Mechanisms of Membrane Transport Laboratory, Institut
Pasteur, 25â28 rue du Docteur Roux, 75015 Paris, France</aff>
      <aff id="A2"><label>2</label>Synchrotron SOLEIL, L'Orme des Merisiers, 91192
Gif-sur-Yvette, France</aff>
      <aff id="A3"><label>3</label>Structural Mass Spectrometry and Proteomics Unit, Institut Pasteur,
25â28 rue du Docteur Roux, 75015 Paris, France</aff>
      <aff id="A4"><label>4</label>UMR 3528, CNRS, Institut Pasteur, 25â28 rue du Docteur Roux,
75015 Paris, France</aff>
      <author-notes>
        <corresp id="CR1"><label>*</label>Correspondence and requests for materials should be addressed to
N.R. (<email>nreyes@pasteur.fr</email>)</corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>14</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>4</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>27</day>
        <month>4</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>10</month>
        <year>2017</year>
      </pub-date>
      <volume>544</volume>
      <issue>7651</issue>
      <fpage>446</fpage>
      <lpage>451</lpage>
      <!--elocation-id from pubmed: 10.1038/nature22064-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, and download text and data-mine the
content in such documents, for the purposes of academic research, subject
always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P1">Human members of the solute carrier 1 (SLC1) family of transporters take
up excitatory neurotransmitters in the brain and amino acids in peripheral
organs. Dysregulation of their functions is associated to neurodegenerative
disorders and cancer. Here we present the first crystal structures of a
thermostabilized human SLC1 transporter, the excitatory amino acid transporter 1
(EAAT1), with and without allosteric and competitive inhibitors bound. The
structures show novel architectural features of the human transporters,
including intra- and extracellular domains with potential roles in transport
function, as well as regulation by lipids and post-translational modifications.
The coordination of the inhibitor in the structures and the change in the
transporter dynamics measured by hydrogen-deuterium exchange mass spectrometry,
reveal an allosteric mechanism of inhibition, whereby the transporter is locked
in the outward-facing states of the transport cycle. Our results provide
unprecedented insights into the molecular mechanisms of function and
pharmacology of human SLC1 transporters.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P2">SLC1 transporters constitute a large family of ion-coupled transporters present
in all kingdoms of life<xref rid="R1" ref-type="bibr">1</xref>. There are seven human
SLC1 transporters (<xref ref-type="fig" rid="F8">Extended Data Fig. 1</xref>) that
evolved to serve two specialized functions<xref rid="R2" ref-type="bibr">2</xref>: in
the central nervous system, SLC1 excitatory amino acid transporters (EAAT1-5) take up
the neurotransmitter glutamate into the cell. In peripheral organs, EAATs take up
glutamate and aspartate, while SLC1 neutral amino acid transporters (ASCT1-2) exchange
small amino acids between the extra- and intracellular compartments, contributing to the
cellular solute homeostasis.</p>
    <p id="P3">Glutamate is the most important excitatory transmitter in the mammalian brain and
it has to be continuously pumped into the cytoplasm to allow for rounds of transmission
and prevent cytotoxicity. This essential neurological function is done by EAAT1-5
expressed at the plasma membrane of astrocytes and neurons<xref rid="R3" ref-type="bibr">3</xref>. In particular, astroglial EAAT1 and EAAT2 orthologs are highly expressed
in the hind- and forebrain, respectively, and are responsible for most of the glutamate
uptake in the rodent brain<xref rid="R4" ref-type="bibr">4</xref>. EAATs are powerful
molecular pumps capable of maintaining up to 10<sup>4</sup>-fold glutamate gradients by
using energy stored in sodium, proton and potassium gradients<xref rid="R5" ref-type="bibr">5</xref>. Remarkably, their dysregulation has been associated with several
neurological diseases, including amyotrophic lateral sclerosis<xref rid="R6" ref-type="bibr">6</xref>, ataxia<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>, stroke<xref rid="R9" ref-type="bibr">9</xref>,
depression<xref rid="R10" ref-type="bibr">10</xref> and glioma<xref rid="R11" ref-type="bibr">11</xref>, making them important drug targets.</p>
    <p id="P4">ASCTs are structurally related to EAATs, and function as sodium-dependent neutral
amino acid exchangers at the plasma membrane<xref rid="R12" ref-type="bibr">12</xref>.
Importantly, ASCT2 is up regulated in several forms of cancer, including melanoma<xref rid="R13" ref-type="bibr">13</xref>, lung<xref rid="R14" ref-type="bibr">14</xref>,
prostate<xref rid="R15" ref-type="bibr">15</xref> and breast cancer<xref rid="R16" ref-type="bibr">16</xref>, and it is a key drug target in cancer
therapy.</p>
    <p id="P5">Despite the need for small compounds that selectively and allosterically modulate
SLC1 human transporters, most of their pharmacology is based on substrate-analogs that
inhibit transport competitively<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref>. The only known selective allosteric modulators
of SLC1 transporters are a series of non-competitive EAAT1-selective inhibitors, of
which
2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
(UCPH<sub>101</sub>) is the best studied<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>. However, its mechanism of
action is still poorly understood at the molecular level.</p>
    <p id="P6">In structural terms, most our knowledge on the transport mechanism and
pharmacology of SLC1 transporters comes from the prokaryotic homolog GltPh that has been
crystallized in the main conformational states of the transport cycle, outward-<xref rid="R21" ref-type="bibr">21</xref> and inward-facing states<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>, as well as in complex
with a non-selective and competitive inhibitor of the EAATs<xref rid="R24" ref-type="bibr">24</xref>, DL-threo-Î²-benzyloxyaspartic acid (TBOA). However, the
presence of amino acid insertions and deletions, as well as important differences in the
transport function and pharmacology of GltPh, make this homolog a limited structural
model to understand the molecular mechanism of the human SLC1 proteins.</p>
    <p id="P7">Here we present 3.1-3.3 Ã X-ray crystal structures of thermostable EAAT1
variants in complex with a substrate (L-aspartate), and the allosteric inhibitor
UCPH<sub>101</sub>. The structures, and supporting functional data, show new
architectural features of the EAATs and ASCTs, and unravel the allosteric mechanism of
UCPH<sub>101</sub>-like inhibitors in atomic detail. Taken together, these
structural data can prove useful for the design of novel allosteric compounds with
improved selectivity for both EAATs and ASCTs.</p>
    <sec id="S1">
      <title>EAAT1 engineering and crystallization</title>
      <p id="P8">Purified wild-type EAAT1 lacks transport activity upon reconstitution in
synthetic liposomes (<xref ref-type="fig" rid="F1">Fig. 1a</xref>), and was
recalcitrant to crystallization. To obtain functional protein suitable for
crystallographic studies, we engineered a thermostable EAAT1, called
EAAT<sub>cryst</sub> that shares an overall ~75% sequence identity with
the wild type, and up to ~90% identity at the C-terminal core of the protein
(<xref ref-type="fig" rid="F8">Extended Data Fig. 1</xref>; <xref ref-type="sec" rid="S10">Methods</xref>), where the transported substrate and coupled ions are
expected to bind<xref rid="R24" ref-type="bibr">24</xref>â<xref rid="R29" ref-type="bibr">29</xref>. Indeed, purified EAAT1<sub>cryst</sub>
reconstituted in liposomes showed robust glutamate uptake that depends on opposite
gradients of sodium and potassium ions across the bilayer (<xref ref-type="fig" rid="F1">Fig. 1a</xref> and <xref ref-type="fig" rid="F9">Extended Data Fig.
2a</xref>), and was inhibited by the EAAT1-selective compound UCPH<sub>101</sub>
(IC<sub>50</sub> of 4.5Â±0.3 Î¼M, Hill coefficient 0.92Â±0.07)
(<xref ref-type="fig" rid="F1">Fig. 1b</xref>). These data show that the
transport mechanism and pharmacological selectivity are conserved in
EAAT1<sub>cryst</sub>.</p>
      <p id="P9">Notably, EAAT1<sub>cryst</sub> crystallized in the presence of
UCPH<sub>101</sub>, and we solved its inhibitor-bound structure (see <xref ref-type="sec" rid="S10">Methods</xref> and <xref ref-type="table" rid="T1">Extended Data Table 1</xref>), but it was refractory to crystallization in the
absence of UCPH<sub>101.</sub> To overcome this, we introduced M231I and F235I
mutations in the inhibitor-binding pocket (<xref ref-type="fig" rid="F8">Extended
Data Fig. 1</xref>), and solved the crystal structures of the so-called
EAAT1<sub>cryst-II</sub> both in the presence and absence of the inhibitor
(<xref ref-type="table" rid="T1">Extended Data Table 1</xref>). Purified
EAAT1<sub>cryst-II</sub> also showed robust sodium- and potassium-dependent
glutamate uptake, while the UCPH<sub>101</sub> IC<sub>50</sub> increased
&gt;30-fold (&gt;131Â±38 Î¼M, Hill coefficient 0.92Â±0.0;
<xref ref-type="fig" rid="F1">Fig. 1a,b</xref>), as expected due to the
mutations in the inhibitor binding pocket (see below).</p>
    </sec>
    <sec id="S2">
      <title>Domain organization</title>
      <p id="P10">The structure of EAAT1<sub>cryst</sub> shows a symmetric homotrimer in a
substrate- and UCPH<sub>101</sub>-bound outward-facing conformation (<xref ref-type="fig" rid="F1">Fig. 1c-e</xref>) with an overall GltPh-like fold<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref>
(<xref ref-type="fig" rid="F10">Extended Data Fig. 3</xref>). Each monomer is
composed of two domains: a scaffold domain (ScaD), including transmembrane helices
TM1-2 and TM4-5; and a transport domain (TranD), including TM3, TM6-8 and re-entrant
helical loops 1-2 (HP1-2; <xref ref-type="fig" rid="F1">Fig. 1f</xref>). The three
ScaDs form a compact central structure with a propeller-like shape that ensures the
trimeric form of the transporter and anchors it to the membrane (<xref ref-type="fig" rid="F11">Extended Data Fig. 4</xref>). The three TranDs are more
peripheral and localize between the blades of the propeller, making protein contacts
exclusively with the ScaDs of their own monomer. The TranD-ScaD interface buries
~3,500 Ã<sup>2</sup>, including a conserved salt bridge between E256
and K364, through interactions of residues in the cytoplasmic parts of HP1, TM7, and
TM3 (TranD), and TM2, TM4c, and TM5 (ScaD). On the extracellular side, additional
contacts occurred between residues in HP2 and TM4 that are well conserved among
human transporters (<xref ref-type="fig" rid="F12">Extended Data Fig. 5</xref>).</p>
      <p id="P11">Substrate and ion translocation in SLC1 transporters is thought to occur
through large rigid-body movements of the TranD, relative to the static ScaD, that
move the cargo in an elevator-like fashion across the membrane<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R30" ref-type="bibr">30</xref>. Thus, during the
isomerization to the inward-facing state the TranD-ScaD interface changes
drastically on the TranD side, and the novel features observed at this interface in
EAAT1<sub>cryst</sub> might influence the distinct TranD dynamics in human SLC1
proteins.</p>
    </sec>
    <sec id="S3">
      <title>Transport domain</title>
      <p id="P12">One of the most remarkable architectural features of the
EAAT1<sub>cryst</sub> TranD is in TM8, where there are deletions and insertions
compared to prokaryotic homologs (<xref ref-type="fig" rid="F2">Fig. 2</xref> and
<xref ref-type="fig" rid="F10">Extended Data Fig. 3</xref>). In
EAAT1<sub>cryst</sub>, TM8 can be divided into extracellular (TM8a),
transmembrane (TM8b), and cytoplasmic (TM8c) helices. The loop connecting TM8a and
HP2 is six residues shorter in human SLC1 transporters, and brings their
extracellular ends in close contact through hydrogen bonding and hydrophobic
interactions (<xref ref-type="fig" rid="F2">Fig. 2</xref>). HP2 is a dynamic element
that controls the access of substrate and ions to their binding sites in the
TranD<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R31" ref-type="bibr">31</xref>â<xref rid="R33" ref-type="bibr">33</xref>, and its
interactions with TM8b likely play an important role in determining HP2 movements.
Consistently, single-cysteine mutations at positions along TM8a in EAAT1<xref rid="R34" ref-type="bibr">34</xref>, and in a rodent EAAT2 ortholog<xref rid="R35" ref-type="bibr">35</xref> impaired glutamate transport, highlighting
the significance of this extracellular region for function.</p>
      <p id="P13">In TM8b, we found strong electron density for the substrate (L-aspartate)
and one of the sodium ions (Na2) in similar sites than in the structures of
prokaryotic homologs<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R29" ref-type="bibr">29</xref> (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Remarkably,
the carboxylate group of D456 (TM8b), which coordinates the Î±-amino group of
the substrate, is also at hydrogen bond distance with the hydroxyl group of S343
(HP1). Moreover, the guanidinium group of R457 (TM8b) engages in hydrogen bonding
with HP1 residue G341, and possibly L340 and T342 that point their backbone carbonyl
oxygen atoms towards TM8b. Residues S343 and R457 are well conserved in human SLC1
transporters, and substitutions at equivalent positions in EAAT1 (S363 and
R477)<xref rid="R36" ref-type="bibr">36</xref>, and EAAT3 (R445)<xref rid="R37" ref-type="bibr">37</xref> inactivate transport. In addition, the
loss-of-function mutation R445W in EAAT3, equivalent to R457 in
EAAT1<sub>cryst</sub>, causes human dicarboxylic aminoaciduria<xref rid="R38" ref-type="bibr">38</xref>. Overall, the functional studies and our
structural data converge to suggest that interactions between conserved human
residues at HP1 and TM8b are important to the correct folding and function of the
transporters.</p>
      <p id="P14">On the cytoplasmic side, TM8 extends beyond the membrane through a
hydrophilic helix (TM8c) that makes contact with TM3 and TM7a (<xref ref-type="fig" rid="F2">Fig. 2</xref>). EAAT2 deletion mutants in this region have a
deleterious effect on transport function and membrane trafficking<xref rid="R39" ref-type="bibr">39</xref>. Accordingly, an EAAT1 deletion in TM8c
decreased glutamate uptake rate by ~2-fold (<xref ref-type="fig" rid="F9">Extended Data Fig. 2b</xref>). Indeed, the functional data and the TM8c amino
acid conservation among EAATs underscore the pivotal role of this novel structural
motif in protein folding and transport kinetics.</p>
    </sec>
    <sec id="S4">
      <title>Scaffold domain</title>
      <p id="P15">The ScaD contains highly divergent regions, especially in TM4 (<xref ref-type="fig" rid="F8">Extended Data Fig. 1</xref>), where
EAAT1<sub>cryst</sub> shows several unique architectural features. On the
extracellular side, TM4a forms inter- and intra-monomeric contacts with TM2 and HP2,
respectively. Moreover, an amino acid insertion between TM4b and TM4c (TM4b-c loop)
that appeared during the evolution of eukaryotic transporters protrudes into the
central vestibule of the EAAT1<sub>cryst</sub> trimer (<xref ref-type="fig" rid="F3">Fig. 3a</xref> and <xref ref-type="fig" rid="F11">Extended Data Fig. 4</xref>).
The TM4b-c loop forms the center of the propeller, and makes extensive contacts
within and between protomers. Although, we could not model the outermost residues in
the TM4b-c loop (Y200-V210), they are expected to each out to the bulk solvent
exposing an N-glycosylation site (N204). Notably, all human SLC1 transporters
contain predicted N-glycosylation sites in the TM4b-c loop, suggesting a conserved
role of this loop in the posttranslational processing of these proteins.</p>
      <p id="P16">On the cytoplasmic side, TM1 bends and re-orients its N-terminal part (TM1a)
nearly parallel to the membrane plane, which forms the tips of the
propellerâs blades (<xref ref-type="fig" rid="F1">Fig. 1c</xref> and <xref ref-type="fig" rid="F3">Fig. 3b</xref>). The position and amphipathic nature of
TM1a suggests that it somehow interacts with the inner leaflet of the membrane.
Consistently, in the hydrophobic crevice between TM1a and HP1a, we observe strong
non-protein electron density that likely corresponds to bound detergent or lipid
molecules (<xref ref-type="fig" rid="F3">Fig. 3b</xref>). Interestingly, a second
hydrophobic crevice between the extracellular part of TM4 and HP2, also shows strong
non-protein electron density (<xref ref-type="fig" rid="F3">Fig. 3a</xref>). A
similar crevice was also noted in a substrate-bound structure of GltPh<xref rid="R21" ref-type="bibr">21</xref>.</p>
      <p id="P17">Lipids strongly regulate SLC1 transport function<xref rid="R40" ref-type="bibr">40</xref>â<xref rid="R44" ref-type="bibr">44</xref>, and those
hydrophobic crevices at the interface between the TranD and ScaD, where large
conformational changes occur during substrate translocation, might constitute sites
for lipid regulation of transport function.</p>
    </sec>
    <sec id="S5">
      <title>UCPH<sub>101</sub> binding site</title>
      <p id="P18">The structure of EAAT1<sub>cryst</sub> showed strong electron density for
UCPH<sub>101</sub> in a hydrophobic pocket between TM3, TM7 and TM4c at the
TranD-ScaD interface, where the compound extends the interface by ~ 500
Ã<sup>2</sup> (<xref ref-type="fig" rid="F1">Fig. 1d,e</xref> and <xref ref-type="fig" rid="F4">Fig. 4a,b</xref>). The chromene skeleton, the parental
group of the UCPH series of compounds, is buried deeply in the domains interface,
and coordinated by a direct ring-stacking interaction with F369 (TM7a), as well as
hydrophobic interactions with G120 (TM3), V373 (TM7a) and M231 (TM4c) (<xref ref-type="fig" rid="F4">Fig. 4b</xref>). In addition, the amine group of
UCPH<sub>101</sub> forms a hydrogen bond with the main-chain carbonyl of F369,
while its carbonitrile group interacts with Y127 (TM3). The methoxy-phenyl and
naphthalene groups appear partially facing the hydrocarbon core of the membrane.
Yet, the former establishes hydrophobic interactions with V124 (TM3), V373 and M231,
while the latter is mainly coordinated by F235 (TM4c). The majority of the
above-mentioned residues are important for UCPH<sub>101</sub> transport inhibition
of an EAAT1 rodent ortholog<xref rid="R20" ref-type="bibr">20</xref>. Furthermore,
the M231I-F235I double mutant (EAAT1<sub>cryst-II</sub>) showed &gt;30-fold
increase in UCPH<sub>101</sub> IC<sub>50</sub> compared to EAAT1<sub>cryst</sub> in
proteo-liposomes (<xref ref-type="fig" rid="F1">Fig. 1b</xref>). Hence, there is an
excellent agreement between the crystallographic and functional data.</p>
      <p id="P19">Several mechanistically-relevant observations can be made regarding the
UCPH<sub>101</sub> binding pocket in EAAT1<sub>cryst</sub>: i) it is over 15
Ã away from the substrate and sodium binding sites, suggesting that
UCPH<sub>101</sub> does not preclude extracellular substrate binding; ii) it
faces the inner leaflet of the membrane, implying that UCPH<sub>101</sub> accesses
its binding site from the lipidic, and not the aqueous phase, when applied
extracellularly; iii) it is fully contained in a single subunit, in agreement with
the lack of cooperativity observed in proteo-liposome (<xref ref-type="fig" rid="F1">Fig. 1b</xref>), and cell assays<xref rid="R20" ref-type="bibr">20</xref>; iv)
a comparison of the EAAT1-5 sequences suggests that the main determinants of
UCPH<sub>101</sub> selectivity for EAAT1 are in TM4c, where M231 and F235 are
the only coordinating residues that differ between EAAT1 and all other EAATs (<xref ref-type="fig" rid="F8">Extended Data Fig. 1</xref>). Consistently, the double
mutant EAAT1<sub>cryst-II</sub> containing EAAT2 residues equivalent to M231-F235 shows a large
IC<sub>50</sub> increase.</p>
    </sec>
    <sec id="S6">
      <title>UCPH<sub>101</sub>-unbound state</title>
      <p id="P20">To better understand the conformational changes of the transporter induced
by UCPH<sub>101</sub>, we set out to determine the structure of the
EAAT1<sub>cryst</sub> UCPH<sub>101</sub>-unbound state, but it was refractory to
crystallization. Instead, we solved the structure of the EAAT1<sub>cryst-II</sub>
UCPH<sub>101</sub>-unbound state and for comparison, the
EAAT1<sub>cryst-II</sub> UCPH<sub>101</sub>-bound state, using an excess of the
compound in the crystallization conditions (see <xref ref-type="sec" rid="S10">Methods</xref>).</p>
      <p id="P21">The EAAT1<sub>cryst-II</sub> UCPH<sub>101</sub>-bound state is nearly
identical to that of the EAAT1<sub>cryst</sub> with the exception of the I231 and
I235 side chains, and a ~2 Ã movement of UCPH<sub>101</sub>
methoxy-phenyl and naphthalene groups away from them (<xref ref-type="fig" rid="F4">Fig. 4c</xref> and <xref ref-type="fig" rid="F13">Extended Data Fig.
6a</xref>). However, the EAAT1<sub>cryst-II</sub> UCPH<sub>101</sub>-unbound
structure shows notable differences with bound state. First, there is no excess
electron density for UCPH<sub>101</sub>, and the side chain of F369 moves outward by
as much as 1.9 Ã, partly occupying the volume of the UCPH<sub>101</sub>
chromene group (<xref ref-type="fig" rid="F4">Fig. 4c</xref>). Second, there is a
small rigid-body movement of the entire TranD that shifts by as much as 0.7
Ã, compared to the UCPH<sub>101</sub>-bound structures (<xref ref-type="fig" rid="F13">Extended Data Fig. 6b</xref>). This conformational change shows the
EAAT1<sub>cryst</sub> TranD is able to move as rigid bodies relative to the
ScaD, and highlights the importance of such movements for the function of the human
transporters, as it has been shown for GltPh<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>.</p>
      <p id="P22">The structural changes observed in the UCPH<sub>101</sub>-unbound structure
unambiguously demonstrate that the assigned binding pocket of UCPH<sub>101</sub> is
correct, and that within the restricted environment of the crystal lattice,
UCPH<sub>101</sub> induces both local and global conformational changes of the
transporter that optimize its coordination in an outward-facing state.</p>
    </sec>
    <sec id="S7">
      <title>Transport domain dynamics</title>
      <p id="P23">The coordination of UCPH<sub>101</sub> in the crystal structures, wedged in
the TranD-ScaD interface, as well as the effect of the M231I-F235I mutations on its potency
strongly suggest that UCPH<sub>101</sub> inhibits transport by trapping the
transporter in an outward-facing state. Consistently, the rigid-body movements of
the TranD to isomerize the transporter into the inward-facing state would separate the coordinating
residues in the TranD from those in the ScaD, and disrupt the UCPH<sub>101</sub>
coordination. Hence, under equilibrium conditions where the transporters are
sampling outward- and inward-facing states, the expected effect of
UCPH<sub>101</sub> binding is to shift the equilibrium in favor of the
outward-facing state.</p>
      <p id="P24">To gain insights into the effects of UCPH<sub>101</sub> binding to the
transporters at equilibrium, we probed the detergent solubilized
EAAT1<sub>cryst</sub> by hydrogen-deuterium exchange mass spectrometry (HDX-MS).
HDX-MS measures the rate of exchange of backbone amide hydrogen atoms that depends
on solvent accessibility and hydrogen bonding, and provides valuable information on
the dynamics and conformational changes of proteins<xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref>.</p>
      <p id="P25">We compared the HDX behavior of the EAAT1<sub>cryst</sub> in the presence
and absence of UCPH<sub>101</sub>. Overall, the deuterium uptake pattern of
EAAT1<sub>cryst</sub> shows dynamic structural elements in both the TranD and
ScaD (<xref ref-type="fig" rid="F14">Extended Data Fig. 7</xref>-<xref ref-type="fig" rid="F15">8</xref>), and reveals the unstructured and
solvent-exposed nature of several regions that were not resolved in the crystal
structures, including the TM3-TM4a (peptide 153-173) and TM4b-c (peptide 200-208)
loops, as well as the N- (peptide 1-28) and C-termini (peptides 490-522) (<xref ref-type="fig" rid="F16">Extended Data Fig. 9</xref>).</p>
      <p id="P26">Binding of UCPH<sub>101</sub> significantly decreased deuterium uptake in
several areas of the TranD including its binding pocket (residues 112-123 and
370-374), and the surrounding area (residues 354-369), while it left the uptake in
the ScaD unchanged (<xref ref-type="fig" rid="F5">Fig. 5a</xref>). It also decreased
deuterium uptake in distant residues (336-349 and 420-430) at the tips of HP1 and
HP2 involved in substrate coordination and occlusion, suggesting that
UCPH<sub>101</sub> induces conformational changes in the transporter upon
binding. To gain insights into the nature of those conformational changes, we first
compared the TranD areas in which UCPH<sub>101</sub> decreased uptake with those
buried at the interface with ScaD in the EAAT1<sub>cryst</sub> structure, and found
that they correlate remarkably well (<xref ref-type="fig" rid="F5">Fig.
5a-c</xref>). Second, we built a model of the EAAT1<sub>cryst</sub> inward-facing
state, based on a recently solved structure of GltPh<xref rid="R23" ref-type="bibr">23</xref>, to assess the changes in solvent accessibility in a possible
transition between inward- and outward-facing states (<xref ref-type="fig" rid="F5">Fig. 5c,d</xref>). Indeed, the comparison between the structure and the model
shows that the UCPH<sub>101</sub>-modified areas detected by HDX-MS transit as rigid
bodies from being solvent-exposed, in the inward-facing state, to buried at the
TranD-ScaD interface, in the outward-facing state. Such conformational change is
expected to decrease the dynamics of alpha helices and/or the solvent accessibility
of the loops in the UCPH<sub>101</sub>-modified areas and thus, is consistent with
the observed decrease in deuterium uptake. Overall, the HDX-MS and structural
analysis support the stabilization of the outward-facing state, at the expense of
the inward-facing state(s), induced by UCPH<sub>101</sub>.</p>
    </sec>
    <sec id="S8">
      <title>UCPH<sub>101</sub>- and TBOA<sub>TFB</sub>-bound state</title>
      <p id="P27">The distant position of UCPH<sub>101</sub> from the substrate and HP2, a
structural element that controls extracellular access to the substrate binding
site<xref rid="R24" ref-type="bibr">24</xref>, suggests that the
UCPH<sub>101</sub>-bound transporters could undergo the conformational changes
required to exchange the substrate with the extracellular solution. To test this, we
solved the crystal structure of EAAT1<sub>cryst</sub> in complex with both
UCPH<sub>101</sub> and
(2<italic>S</italic>,3<italic>S</italic>)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate
(TBOA<sub>TFB</sub>), a potent and non-selective TBOA derivative<xref rid="R47" ref-type="bibr">47</xref>, at 3.7 Ã resolution (<xref ref-type="table" rid="T1">Extended Data Table 1</xref>).</p>
      <p id="P28">Overall, the UCPH<sub>101</sub>-TBOA<sub>TFB</sub>-bound structure is
similar to that of the UCPH<sub>101</sub>-bound state, with the exception of HP2
that adopts an âopenâ conformation and packs against the TM4b-c loop,
disrupting the coordination of the Na2 (<xref ref-type="fig" rid="F6">Fig.
6a,b</xref>). These conformational changes resemble those previously observed in
the structure of the GltPh-TBOA complex, and are in excellent agreement with the
proposed competitive inhibitory mechanism of TBOA-like compounds<xref rid="R24" ref-type="bibr">24</xref>.</p>
      <p id="P29">In the substrate-binding site, we observed excess electron density for the
bulky TBOA<sub>TFB</sub> (<xref ref-type="fig" rid="F6">Fig. 6c</xref>), but due to
lack of resolution, we were not able to unambiguously orient the compound. Hence, we
initially positioned the TBOA moiety of TBOA<sub>TFB</sub> using the TBOA-bound
GltPh structure as a guide. After crystallographic refinement, the additional
benzoylamino and trifluoromethyl groups of TBOA<sub>TFB</sub> in
EAAT1<sub>cryst</sub> localized in a hydrophobic cavity mainly formed by
residues in HP1b and TM7a, and possibly by residues in TM2 and TM4c, likely
explaining the observed ~1500-fold increase in EAAT1 inhibitory potency over
TBOA<xref rid="R47" ref-type="bibr">47</xref>.</p>
      <p id="P30">Indeed, in the TBOA<sub>TFB</sub>-bound structure UCPH<sub>101</sub> is
bound with an identical coordination than in the substrate-bound state. Therefore,
the EAAT1<sub>cryst</sub> structures show that UCPH<sub>101</sub> binding at its
allosteric site does not preclude the movements of HP2 involved in substrate and
sodium binding from the extracellular solution.</p>
    </sec>
    <sec id="S9">
      <title>Inhibitory mechanisms of EAAT1</title>
      <p id="P31">The structural and functional EAAT1<sub>cryst</sub> data reveal new
architectural features of human SLC1 transporters, and their first molecular
mechanism of allosteric inhibition. UCPH<sub>101</sub> binding âgluesâ
the TranD to the ScaD in the outward-facing states, and precludes substrate
translocation, but not binding from the extracellular solution (<xref ref-type="fig" rid="F7">Fig. 7</xref>). Non-conserved residues in the ScaD determined
UCPH<sub>101</sub> selectivity for EAAT1. This inhibitory mechanism contrasts
with that of substrate-analog inhibitors like TBOA. The binding pocket of TBOA-like
compounds overlaps with the conserved substrate binding site<xref rid="R24" ref-type="bibr">24</xref>, explaining their lack of selectivity among glutamate
transporters and the inhibition of substrate binding observed on either side of the
membrane<xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref>.</p>
      <p id="P32">The unique inhibitory mechanism of UCPH<sub>101</sub> makes it an extremely
valuable pharmacological tool to study the conformational changes that EAAT1
undergoes upon substrate and ion binding. Remarkably, the UCPH<sub>101</sub>
allosteric binding site highlights a cavity that can facilitate the design of
selective compounds for other human SLC1 transporters, and possibly the long-sought
positive modulators of glutamate uptake.</p>
    </sec>
    <sec sec-type="methods" id="S10" specific-use="web-only">
      <title>Methods</title>
      <sec id="S11">
        <title>Construct optimization</title>
        <p id="P33">We used fluorescence-detection size-exclusion chromatography (FSEC)<xref rid="R50" ref-type="bibr">50</xref> to screen solubilization conditions and
EAAT1 variants fused to enhanced green fluorescent protein (eGFP). EAAT1
N-terminal fusions solubilized in dodecanoyl sucrose (DDS, Anatrace) were found
to have good solubility and mono-dispersity by FSEC in clear lysates. However,
EAAT1 looses its transport activity and chromatographic monodispersity upon
purification. To increase its stability, we used consensus mutagenesis<xref rid="R51" ref-type="bibr">51</xref>, and screened EAAT1 variants with
different consensus mutations in the predicted transmembrane helices by FSEC.
The apparent melting temperature (Tm) of the most stable EAAT1 construct was
&gt;20 <bold>Â°</bold>C over that of the wild-type EAAT1, but the
mutated transporter was still refractory to crystallization. We reasoned that
the divergent extracellular region between TM3-4c could interfere with
crystallization, and changed it for the equivalent region in ASCT2, the shortest
one among human SLC1 members (<xref ref-type="fig" rid="F8">Extended Data
Fig.1</xref>). In addition, we mutated the two predicted N-glycosylation
sites of the transporter (N155T and N204T mutations) to further improve
crystallizability.</p>
      </sec>
      <sec id="S12">
        <title>Expression and purification</title>
        <p id="P34">All constructs were introduced into pcDNA3.1(+) (Invitrogen) with
N-terminal Strep-tag II affinity tag followed by eGFP and PreScission protease
cleavage site, and expressed in HEK293F cells (ATCC, mycoplasma test negative)
grown in Excell293 medium (Sigma) and supplemented with 4mM L-glutamine (Sigma)
and 5Âµg/ml Phenol red (Sigma-Aldrich) to densities of 2.5 x
10<sup>6</sup> cells ml<sup>-1</sup>. Cells were transiently transfected in
Freestyle293 medium (Invitrogen) using poly-ethylenimine (PEI) (Polysciences) at a
density of 2.5 x 10<sup>6</sup> cells ml<sup>-1</sup>, diluted with an
equivalent volume of Excell293 6 hours post-transfection, and treated with 2.2
mM valproic acid (Sigma) 12 hours after dilution of the cultures. Cells were
collected at ~48 h post-transfection.</p>
        <p id="P35">Initial screens of constructs and detergent solubilization buffers were
done in small-scale (5-10 ml), and cells were collected, mechanically disrupted
with a douncer and solubilized in 50 mM HEPES/Tris-base, pH 7.4, 200 mM NaCl
buffer supplemented with 1 mM L-asp, 1 mM EDTA, 1 mM Phenylmethylsulfonyl
fluoride (PMSF), 1 mM Tris(2-carboxyethyl)phosphine (TCEP), 1:200 (v/v) dilution
of mammalian protease inhibitor cocktail (Sigma), 10 % glycerol, 2% detergent
and 0.4% cholesterol hemisuccinate (CHS) (Anatrace). After 1-hour incubation at
4 <bold>Â°</bold>C, clear lysates were obtained by ultracentrifugation
(247,000 g for 45 min). A high-throughput auto-sampler was used to inject the
lysates in a SRT SEC-500 column (Sepax Technologies) equilibrated in 50 mM
HEPES/Tris-base, pH 7.4, 200 mM NaCl buffer supplemented with 1 mM L-asp, 1 mM
(TCEP), 5 % glycerol, 3 x CMC detergent, and ~0.01% CHS, in line with
fluorescence detection (Photon technology international) for FSEC analysis.</p>
        <p id="P36">Large-scale expression was done in 2-4 l cultures with cells collected
in 50 mM HEPES/Tris-base, pH 7.4, 50 mM NaCl buffer supplemented with 1 mM
L-asp, 1 mM EDTA, 1 mM PMSF, 1 mM TCEP, and 1:200 (v/v) dilution of mammalian
protease inhibitor cocktail (Sigma), and disrupted in an cell homogenizer
(EmulsiFlex-C5, Avestin) after 3 runs at 15,000 Psi. The resulting homogenate
was clarified by centrifugation (4,500 <italic>g</italic>, 0.5 h) and the crude
membranes were collected by ultracentrifugation (186,000 g for 1.5 h). Membranes
were washed once with the above-mentioned buffer and finally homogenized with a
douncer in a buffer containing 50 mM HEPES/Tris-base, pH 7.4, 200 mM NaCl, 1 mM
L-asp, 1 mM EDTA, 1 mM TCEP, and 10% Glycerol, snap-frozen in liquid
N<sub>2</sub> and stored at -80Â°C at 0.5 g of membranes
ml<sup>-1</sup>.</p>
        <p id="P37">Membrane solubilization was done by thawing out and supplementing the
membrane homogenate with 2% DDS, 0.4% CHS, and 25 Î¼M UCPH<sub>101</sub>
(Abcam). After 1-hour incubation, the insoluble material was removed by
ultracentrifugation (186,000<italic>g</italic> for 1 h), and Strep-Tactin
sepharose resin (GE Healthcare) was added to the supernatant and rotated for 2
h. Resin was washed with 25 column volumes of 50 mM HEPES/Tris-base, pH 7.4, 200
mM NaCl, 1 mM L-asp, 1 mM TCEP, 5% Glycerol, 0.05% DDS, 0.01% CHS and 25
Î¼M UCPH<sub>101</sub>, and the protein was eluted with the same buffer
supplemented with 2.5 mM D-desthiobiotin.</p>
        <p id="P38">The eluted eGFP-transporter fusion was concentrated to 1-2 mg
ml<sup>-1</sup> using 100-kDa cutoff membranes (Millipore), and digested
with His-tagged PreScission protease overnight at 4 Â°C. The protease was
removed by reverse Ni-NTA (Qiagen) affinity chromatography, and the flow through
containing the transporter was concentrated to 500 Î¼l, ultra-centrifuged
(86,900 <italic>g</italic>, 20 min), and applied to a Superose 6 10/300 gel
filtration column (GE Healthcare) equilibrated with 50 mM HEPES/Tris-base, pH
7.4, 200 mM NaCl, 1 mM L-asp, 1 mM TCEP, 5% Glycerol, 0.25% decanoyl sucrose
(DS, Sigma), 0.05% CHS and 100 Î¼M UCPH<sub>101</sub>. To obtain the
UCPH<sub>101</sub> unbound structure, the protocol was identical, but the
allosteric inhibitor was omitted from all buffers. To obtain the
UCPH<sub>101</sub>-TBOA<sub>TFB</sub> bound structure, the protein sample
was supplemented with 3 mM TBOA<sub>TFB</sub> (Tocris) before the injection in
the gel filtration column equilibrated with 50 mM HEPES/Tris-base, pH 7.4, 200
mM NaCl, 1 mM TCEP, 5% Glycerol, 0.25% decanoyl sucrose (DS, Sigma), 0.05% CHS,
300 Î¼M TBOA<sub>TFB</sub> and 100 Î¼M UCPH<sub>101</sub>.</p>
        <p id="P39">Protein samples after the solubilization step were kept on ice or at 4
Â°C at all times.</p>
      </sec>
      <sec id="S13">
        <title>Crystallization and structure determination</title>
        <p id="P40">Purified protein was concentrated to 3.5-4.0 mg ml<sup>-1</sup> and 1 mM
UCPH<sub>101</sub> was added in experiments with the inhibitor-bound
transporters. Initial vapor diffusion crystallization screens were done by
mixing 300 nl of protein and reservoir solution in sitting drops, dispensed by a
Mosquito robot (TTP labtech) in 96-well Greiner plates. The purified
transporters form three-dimensional crystals in several conditions containing
low molecular weight polyethylene glycols. The best-diffracting crystals were
obtained after manual optimization using 1.6 Î¼l hanging drops at 4
Â°C, obtained by mixing equal volumes of protein supplemented with 0.2%
n-Octyl-b-D-glucopyranoside (BOG, Anatrace) and 0.04% CHS, and reservoir
solutions containing 100 mM Tris, pH 8.2, 50 mM CaCl<sub>2</sub>, 50 mM
BaCl<sub>2</sub>, and 28-30% PEG 400. Crystals appeared after 24-48 h and
reached their maximum size after a week. Crystals were flash-frozen in liquid
nitrogen before X-ray diffraction data collection without any further cryo
protection.</p>
        <p id="P41">X-ray diffraction data were collected at beamlines PROXIMA-1 at the
SOLEIL synchrotron (St Aubin, France) and at beamlines at the European
Synchrotron Radiation Facility (Grenoble, France). In general, 2-3 data sets
from single crystals were collected, and indexed, integrated, scaled and merged
using XDS package<xref rid="R52" ref-type="bibr">52</xref>. Due to the
anisotropic nature of the diffraction data, the DEBYE and STARANISO programs
were applied to scale it using the STARANISO server (<ext-link ext-link-type="uri" xlink:href="http://staraniso.globalphasing.org/">http://staraniso.globalphasing.org/</ext-link>). The software performs an
anisotropic cut-off of merged intensity data with a Bayesian estimation of the
structure amplitudes, and applies an anisotropic correction to the data. Table 1
shows the refinement statistics for the full sets of reflections truncated at
the best high-resolution along h, k or l axis, values given by AIMLESS<xref rid="R53" ref-type="bibr">53</xref>, before the anisotropic corrections
computed by the STARANISO software. The corrected anisotropic amplitudes were
then used for molecular replacement in PHASER<xref rid="R54" ref-type="bibr">54</xref>, using the scaffold and transport domains of GltPh (PDB code
2NWL) as independent search models. The initial electron density maps were
clearly interpretable, and the final model was obtained through rounds of manual
building in COOT<xref rid="R55" ref-type="bibr">55</xref> and refinement in
Buster<xref rid="R56" ref-type="bibr">56</xref>, until reaching good
crystallographic statistics and stereochemistry (<xref ref-type="table" rid="T1">Extended Data Table 1</xref>). The model contains one EAAT1<sub>cryst</sub>
monomer per asymmetric unit and most of the EAAT1<sub>cryst</sub> polypeptide
(residues 37-487), with the exception of some residues in the extracellular
loops between TM3-4a, TM4b-4c, TM5-6 and TM7b-HP2a. Sequence assignment was
aided by anomalous difference Fourier maps from diffraction data collected with
low energy X-rays (1.77 Ã) to highlight the sulfur atoms of methionine
and cysteine residues (<xref ref-type="fig" rid="F13">Extended Data Fig.
6c,d</xref>). EAAT1<sub>cryst-II</sub>, as well as the EAAT1<sub>cryst</sub>
UCPH<sub>101</sub>-TBOA<sub>TFB</sub> bound structures were solved by the
same approach above mentioned, but using the EAAT1<sub>cryst</sub> TranD and
ScaD as independent search models for molecular replacement.</p>
        <p id="P42">The stereochemical properties of the final models were analyzed with the
Molprobity server (<ext-link ext-link-type="uri" xlink:href="http://molprobity.biochem.duke.edu/">http://molprobity.biochem.duke.edu/</ext-link>). At least 95% of the
residues in all models are in the Ramachandran favored region. Protein
interfaces were analyzed with the PISA server (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html">http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html</ext-link>). Structural
alignments were done with Superpose in the CCP4 suite. All structural figures
were prepared with PyMOL Molecualr Graphics System, Schrodinger, LLC.</p>
      </sec>
      <sec id="S14">
        <title>Radioactive substrate transport assays</title>
        <p id="P43">Unilamellar liposomes were made at 9:1 molar ratio of
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) and CHS,
in a buffer containing 50 mM HEPES/Tris-base, pH 7.4, 200 mM NaCl and 1 mM
L-asp. The transporters were purified as described above, but excluding the
reverse chromatography step after protease cleavage, and using a Superose 6
10/300 column equilibrated with 50 mM HEPES/Tris-base, pH 7.4, 200 mM NaCl, 1 mM
L-asp, 0.5 mM TCEP, 0.0632% DDS, 0.01264% CHS, and 5% glycerol.</p>
        <p id="P44">To reconstitute the protein, liposomes were first mixed with DDS at a
1:2 (w/w) lipid-to-detergent ratio for 1 h, and then the purified transporters
were added at a 1:40 (w/w) protein-to-lipid ratio. Detergent removal was done at
4Â° C using SM-2 biobeads (BioRad) at 100 mg ml<sup>-1</sup>. The internal
solution of the liposomes was exchanged using 10 freeze-thaw cycles in the
appropriate buffer. After extrusion through 400-nm polycarbonate membranes
(Avanti Polar Lipids), the proteoliposomes were concentrated by
ultracentrifugation (150,000 g for 30 min at 4Â°C) and resuspended at 20
mg of lipids ml<sup>-1</sup>, for immediate use.</p>
        <p id="P45">Substrate transport was assayed at 37Â°C. The uptake reaction was
initiated by diluting the proteo-liposomes 10-fold into a buffer containing 50
mM HEPES/Tris-base, pH 7.4, 200 mM NaCl, 50 ÂµM L-glutamate, and 5
ÂµM [<sup>14</sup>C]-L-glutamate (PerkinElmer), and 2.5% glycerol. After
30 min, 200-Âµl aliquots were diluted 5-fold into ice-cold quench buffer
(50 mM HEPES/Tris-base, pH 7.4, 200 mM ChCl, and 2.5% glycerol), followed by
immediate filtration and wash on nitrocellulose 0.22-Âµm filters
(Millipore). Radioactivity was quantified by liquid scintillation using a
Tri-Carb 3110TR counter (PerkinElmer). For the UCPH<sub>101</sub> titrations,
proteo-liposomes were both pre-incubated for 20 min at room temperature, and
assayed in the presence of UCPH<sub>101</sub>. Background radioactivity was
estimated from protein-free liposomes, and subtracted from the uptake data. Data
was fitted to a Hill equation of the form:</p>
        <p id="P46">F=F<sub>â</sub> +
ÎF<sub>â</sub>/(1+(IC<sub>50</sub>/[UCPH<sub>101</sub>])<sup>n</sup>)</p>
        <p id="P47">Where F<sub>â</sub> is the final level of inhibition,
ÎF<sub>â</sub> is the final amplitude of the
UCPH<sub>101</sub> effect, and n is the Hill coefficient.</p>
        <p id="P48">To titrate the rate of L-glutamate transport by EAAT1<sub>cryst</sub>,
proteo-liposomes were assayed in the presence of 0, 5, 50 or 200 Î¼M
L-glutamate supplemented with 1, 5, 5, or 5 Î¼M
[<sup>14</sup>C]-L-glutamate, respectively. At each substrate concentration, the
initial rate of transport was calculated by a linear fit to 120 s and 180 s
uptake measurements with origin fixed at zero. Background radioactivity was
estimated from protein-free liposomes, and subtracted from the uptake data.</p>
        <p id="P49">For the cell-based transport uptake, cells were collected 36 h
post-transfection, and washed three times and resuspended at a density of 50 x
10<sup>6</sup> cells ml<sup>-1</sup> in 11 mM HEPES/Tris-base, pH 7.4, 140
mM ChCl, 4.7 mM KCl, 2.5 mM CaCl<sub>2</sub>, 1.2 mM MgCl<sub>2</sub>, and 10 mM
D-glucose, for immediate use. The uptake assay was performed similarly to the
one described for the proteo-liposomes, but using a reaction buffer containing
11 mM HEPES/Tris-base, pH 7.4, 140 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl<sub>2</sub>,
1.2 mM MgCl<sub>2</sub>, 10 mM D-glucose, 50 ÂµM L-glutamate, and 5
ÂµM [<sup>14</sup>C]-L-glutamate, and 0.8-Âµm nitrocellulose
filters. Background radioactivity was estimated from cells transfected with
empty vector, and subtracted from the uptake data.</p>
      </sec>
      <sec id="S15">
        <title>Hydrogen-deuterium exchange mass spectrometry</title>
        <p id="P50">HDX-MS experiments were performed with transporters purified as
described in the proteo-liposome section, and using a Superose 6 5/150 gel
filtration column equilibrated with 50 mM HEPES/Tris-base, 200 mM NaCl, pH7.4, 1
mM L-asp, 0.5 mM TCEP, 0.0632% DDS, 0.01264% CHS, and 5% glycerol.</p>
        <p id="P51">The purified EAAT1<sub>cryst</sub> was incubated in ice for 30 min with
2.2% DMSO at a monomer concentration of 5.2 ÂµM, in the presence and
absence of 102 ÂµM UCPH<sub>101</sub>, respectively. Prior to labeling, 10
ÂµL of the unbound and UCPH<sub>101</sub>-bound EAAT1<sub>cryst</sub>
solution was equilibrated for 10 min at room temperature. Deuterium exchange was
initiated by adding 40 ÂµL of D<sub>2</sub>O buffer (50 mM HEPES, pD 7.3,
200 mM NaCl, 1 mM L-asp, 5% glycerol, 0.0632% DDS, 0.01264% CHS, 0.5 mM TCEP)
supplemented or not with 101.2 ÂµM UCPH<sub>101</sub>. Assuming that the
K<sub>D</sub> and IC<sub>50</sub> values of UCPH<sub>101</sub> are similar,
~96% of the transporters would remain bound during deuterium labeling.
Aliquots of 10.4 pmols of protein were removed at defined deuterium exchange
time points (from 10 sec to 60 min) and quenched upon mixing with an ice-cold
acidic solution (0.75% formic acid, 5% glycerol) to decrease the pH to 2.6.
Quenched samples were immediately snap-frozen in liquid N<sub>2</sub> and stored
at -80Â°C until analysis.</p>
        <p id="P52">Prior to mass analysis, quenched samples were rapidly thawed and
immediately injected into a cooled nanoACQUITY UPLC HDX system (Waters corp.)
maintained at 0Â°C. 8.6-pmol protein samples were on-line digested for 2
min at 20 Â°C using an in-house packed immobilized pepsin cartridge (2.0 x
20 mm, 66 ÂµL bed volume). The resulting peptides were trapped and
desalted onto a C18 Trap column (VanGuard BEH 1.7 Âµm, 2.1 x 5 mm, Waters
corp.) at a flow rate of 100 ÂµL/min of 0.15% formic acid, and then
separated in 10 min by a linear gradient of acetonitrile from 5 to 40% at 40
ÂµL/min using an ACQUITY UPLCâ¢ BEH C18 analytical column (1.7
Âµm, 1 x 100 mm, Waters corp.). After each run, the pepsin cartridge was
manually cleaned with two consecutive washes of 1% formic acid, 5% acetonitrile,
1.5 M guanidinium chloride, pH 2.5. Blank injections were performed between each
run to confirm the absence of carry-over.</p>
        <p id="P53">Mass spectra were acquired in resolution and positive mode on a Synapt
G2-Si HDMS mass spectrometer (Waters corp.) equipped with a standard
electrospray ionization source, as described previously<xref rid="R57" ref-type="bibr">57</xref>. Peptides were identified from undeuterated protein
samples acquired in MS<sup>E</sup> mode by database searching in ProteinLynX
Global Server 3.0 (Waters corp.). Each fragmentation spectrum was manually
inspected for assignment validation. Deuterium uptake values were calculated for
each peptide using DynamX 3.0 (Waters corp.). Only one unique charge state was
considered per peptide and no adjustment was made for back-exchange. HDX-MS
results are reported as relative deuterium uptake values expressed in mass unit
or fractional exchange<xref rid="R57" ref-type="bibr">57</xref>. A statistical
analysis was performed with MEMHDX<xref rid="R58" ref-type="bibr">58</xref>
using a False Discovery Rate of 1%.</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S16">
      <title>Extended Data</title>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Figure 1</label>
        <caption>
          <title>Alignment of human SLC1 transporters.</title>
          <p id="P54">Amino acid sequences of EAAT1-5, ASCT1-2 and EAAT1<sub>cryst</sub>
are compared. The boundaries of the Î±-helices (cylinders) in the
TranD (orange) and the ScaD (teal) seen in the EAAT1<sub>cryst</sub>
structure are shown. In order to confer crystallizability, the region
between TM3 and TM4c (arrows) from ASCT2 was transferred to a thermally
stabilized EAAT1. To further improve crystal formation in the absence of
UPCH<sub>101</sub>, mutations M231I and F235I (circles) were introduced
to generate EAAT1<sub>cryst-II</sub>. These substitutions are found in
EAAT2. Other residues involved in UPCH<sub>101</sub> coordination are more
conserved (triangles). Sequences were aligned with Jalview<xref rid="R59" ref-type="bibr">59</xref>.</p>
        </caption>
        <graphic xlink:href="emss-71849-f008"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Figure 2</label>
        <caption>
          <title>EAAT1<sub>cryst</sub> and EAAT1 glutamate uptake.</title>
          <p id="P55"><bold>a,</bold> Initial rates of L-glutamate uptake from purified
EAAT1<sub>cryst</sub> reconstituted in liposomes. The solid line is the
fit of a Michaelis-Menten equation to the data with K<sub>M</sub>=21
Â± 10 Î¼M and V<sub>max</sub>= 13 Â± 1 pmol
Î¼g<sup>-1</sup> protein min<sup>-1</sup>. The graph is the mean
of three independent experiments, and error bars represent s.e.m..
<bold>b,</bold> L-glutamate uptake was measured in HEK293 cells
expressing WT EAAT1 (black circles) and a truncated mutant beyond E501 (red
symbols). The initial rate of uptake decreased by ~2-fold in the
EAAT1 truncated mutant. Data were normalized to the asymptotic level of
glutamate uptake based on a monoexponential function. The rates obtained
from the fits were 0.16 Â± 0.03 and 0.08 Â± 0.03
min<sup>-1</sup> for EAAT1 and the truncated mutant, respectively. The
graphs are means of 4 independent experiments done in duplicates. Error bars
represent the s.e.m..</p>
        </caption>
        <graphic xlink:href="emss-71849-f009"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Figure 3</label>
        <caption>
          <title>EAAT1<sub>cryst</sub> and GltPh structural comparison.</title>
          <p id="P56"><bold>a-b</bold> EAAT1<sub>cryst</sub> aligns to a monomer of GltPh
(PDB 2NWL) with Î±-carbon r.m.s.d. of 1.4 Ã. The ScaDs
(EAAT1<sub>cryst</sub> teal, and GltPh purple, <bold>a</bold>), and
TranDs (EAAT1<sub>cryst</sub> orange and GltPh, purple, <bold>b</bold>) are
shown separately for clarity of display.</p>
        </caption>
        <graphic xlink:href="emss-71849-f010"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Figure 4</label>
        <caption>
          <title>EAAT1<sub>cryst</sub> trimeric interface.</title>
          <p id="P57"><bold>a-b</bold>, Interface of three ScaDs of the
EAAT1<sub>cryst</sub> UCPH<sub>101</sub>-bound structure viewed from the
extracellular side (<bold>a</bold>) and from the membrane (<bold>b</bold>).
The TranDs are not shown. The ScaD of one monomer (black) buries 3,000
Ã<sup>2</sup> in the trimerization interface through extensive
contacts with the two other subunits (teal and purple surfaces), including
six intermolecular salt bridges (shown as green sticks for the monomer in
black). The surface area in the other two monomers is colored in light pink.
Only residues that contribute â¥ 10 Ã<sup>2</sup> of buried
surface area are highlighted.</p>
        </caption>
        <graphic xlink:href="emss-71849-f011"/>
      </fig>
      <fig id="F12" orientation="portrait" position="anchor">
        <label>Extended Data Figure 5</label>
        <caption>
          <title>TranD-ScaD interface.</title>
          <p id="P58"><bold>a-b</bold>, EAAT1<sub>cryst</sub> monomer viewed from the
membrane (solid black line). Residues in the TranD (colored black) bury
1,760 Ã<sup>2</sup> at the interface with the ScaD (<bold>a</bold>).
This interface extends to the extracellular side of the transporter through
interactions between HP2-TM4 (sticks and pseudo-transparent spheres)
(<bold>b</bold>). <bold>c</bold>, Cytoplasmic view of the monomer
displaying the salt bridge between TM7 and TM5.</p>
        </caption>
        <graphic xlink:href="emss-71849-f012"/>
      </fig>
      <fig id="F13" orientation="portrait" position="anchor">
        <label>Extended Data Figure 6</label>
        <caption>
          <title>Superposition of EAAT1<sub>cryst</sub> and EAAT1<sub>cryst-II</sub>
structures.</title>
          <p id="P59"><bold>a-b</bold>, The transport domains of EAAT1<sub>cryst</sub>
(teal) and EAAT1<sub>cryst-II</sub> (pink) UCPH<sub>101</sub>-bound
structures superimpose accurately after aligning their scaffold domains
(<bold>a</bold>). The overall Î±-carbon r.m.s.d. was 0.3 Ã.
However, the same alignment done with EAAT1<sub>cryst-II</sub>
UCPH<sub>101</sub>-bound and -unbound structures shows a small but
global movement of the transport domain (<bold>b</bold>), with a small
increase in the overall Î±-carbon r.m.s.d. of 0.1 Ã.
<bold>c,d</bold> Anomalous difference Fourier maps contoured at the
2.8<italic>Ï</italic> (pink mesh), from data collected at low
energy X-rays (1.77 Ã), show the correct sequence registry in both
the TranD (orange, <bold>a</bold>) and the ScaD (teal, <bold>b</bold>).</p>
        </caption>
        <graphic xlink:href="emss-71849-f013"/>
      </fig>
      <fig id="F14" orientation="portrait" position="anchor">
        <label>Extended Data Figure 7</label>
        <caption>
          <title>Peptide coverage map of EAAT1<sub>cryst</sub>.</title>
          <p id="P60">A total of 111 peptides covering 76.3% of the EAAT1<sub>cryst</sub>
sequence were identified by data independent MS/MS acquisition after 2 min
digestion with immobilized pepsin. Each bar below the EAAT1<sub>cryst</sub>
sequence corresponds to a unique peptide. The 57 peptides colored in blue
were further selected for HDX-MS data extraction and analysis. The two
additional N-terminal residues (<italic>i.e.,</italic> GP) that remain after
protein purification are also shown. The transmembrane helices (TM) of the
TranD (orange) and the ScaD (cyan) are indicated above the sequence.</p>
        </caption>
        <graphic xlink:href="emss-71849-f014"/>
      </fig>
      <fig id="F15" orientation="portrait" position="anchor">
        <label>Extended Data Figure 8</label>
        <caption>
          <title>UCPH<sub>101</sub> effect on the local hydrogen exchange behavior of
EAAT1<sub>cryst</sub>.</title>
          <p id="P61"><bold>a</bold>, HDX profiles of EAAT1<sub>cryst</sub> (see <xref ref-type="sec" rid="S10">Methods</xref>) in the apo (upper panel) and
UCPH<sub>101</sub>-bound state (middle panel). The relative fractional
uptake determined for each peptide and at each time point is plotted as a
function of peptide position. The black to red lines correspond to data
acquired from 10 sec up to 1h, respectively. <bold>b</bold>, The fractional
uptake difference plot was generated by subtracting the deuterium uptake
values in the UCPH<sub>101</sub>-unbound from those in the bound state.
Negative uptake difference indicates UCPH<sub>101</sub>-induced decrease in
amide hydrogen exchange. Each dot corresponds to an average of three
independent HDX-MS experiments. The four regions (labeled 1 to 4) showing a
statistically significant modification (<italic>p</italic> &lt;0.01) of
deuterium uptake upon binding of UCPH<sub>101</sub> are highlighted in
grey.</p>
        </caption>
        <graphic xlink:href="emss-71849-f015"/>
      </fig>
      <fig id="F16" orientation="portrait" position="anchor">
        <label>Extended Data Figure 9</label>
        <caption>
          <title>HDX-MS results mapped on the crystal structure of ScaD and TranD of
EAAT1<sub>cryst</sub> in the unbound and UCPH<sub>101</sub>-bound
state.</title>
          <p id="P62">The color code at the bottom shows the average relative fractional
uptake measured in both domains after 10 sec (upper panel), 10 min (middle
panel) and 1h (lower panel) labeling. Missing regions in the crystal
structure are represented by dashed lines. Peptides showing a statistically
significant (<italic>p</italic> &lt;0.01) modification of deuterium
uptake upon UCPH<sub>101</sub> binding are labeled. Uncovered regions are
colored in light blue.</p>
        </caption>
        <graphic xlink:href="emss-71849-f016"/>
      </fig>
      <fig id="F17" orientation="portrait" position="anchor">
        <label>Extended Data Figure 10</label>
        <graphic xlink:href="emss-71849-f017"/>
      </fig>
      <table-wrap id="T1" position="anchor" orientation="portrait">
        <label>Extended Data Table 1</label>
        <caption>
          <title>Data collection and refinem ent statistics.</title>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <th align="left" valign="top" rowspan="1" colspan="1">EAATl<sub>cryst</sub><break/>UCPH<sub>101</sub><break/>bound</th>
              <th align="left" valign="top" rowspan="1" colspan="1">EAATI<sub>cryst-II</sub><break/>UCPH<sub>101</sub><break/>bound</th>
              <th align="left" valign="top" rowspan="1" colspan="1">EAATI<sub>cryst-II</sub></th>
              <th align="left" valign="top" rowspan="1" colspan="1">EAATl<sub>cryst</sub><break/>UCPH<sub>101</sub>
and<break/>TBOA<sub>TFB</sub><break/>bound</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>Data collection</bold>
<xref ref-type="table-fn" rid="TFN2">*</xref>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Space group</td>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>6<sub>3</sub></td>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>6<sub>3</sub></td>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>6<sub>3</sub></td>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>6<sub>3</sub></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Cell dimensions</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â <italic>a=b, c</italic>
(Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">123.27, 89.87</td>
              <td align="left" valign="top" rowspan="1" colspan="1">123.11, 89.62</td>
              <td align="left" valign="top" rowspan="1" colspan="1">123.32, 89.57</td>
              <td align="left" valign="top" rowspan="1" colspan="1">124.33, 90.81</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â Î±=Î², Î³
(Â°)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">90.0, 120.0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">90.0, 120.0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">90.0, 120.0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">90.0, 120.0</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Wavelength</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.979</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.976</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.009</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.977</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Resolution (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">34.50-<bold>3.25</bold> (3.34-3.25)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">45.82 -<bold>3.1</bold> (3.18-3.1)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">45.87-<bold>3.32</bold> (3.41-3.32)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">46.31-<bold>3.71</bold> (3.81-3.71)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Anisotropy direction<xref ref-type="table-fn" rid="TFN3">$</xref><break/>Resolution
where<break/>CC<sub>1/2</sub> &gt;0.3</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Overall (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.37</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.32</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.71</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">along h, k axis (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.75</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.68</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.85</td>
              <td align="left" valign="top" rowspan="1" colspan="1">4.35</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">along l axis (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>3.25</bold>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>3.1</bold>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>3.32</bold>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>3.71</bold>
</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Measured reflections</td>
              <td align="left" valign="top" rowspan="1" colspan="1">333978 (24261)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">290672 (21906)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">326273 (21829)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">141904 (11176)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Unique reflections</td>
              <td align="left" valign="top" rowspan="1" colspan="1">12338 (902)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">14115 (1 032)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">11556 (834)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">8570 (628)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Completeness (%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">100 (100)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">99.9 (99.9)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">100 (100)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">99.9 (100.0)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Mn (I) half-set correlation</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.99 (0.22)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1 (0.43)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.99 (0.31)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.99 (0.373)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>I</italic>/Ï<italic>(I)</italic></td>
              <td align="left" valign="top" rowspan="1" colspan="1">11.7 (0.7)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15.8 (0.8)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">13 (0.7)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">12.1 (0.9)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
<italic>R</italic>
<sub>merge</sub>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.19 (6.8)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.1 (6.71)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.15 (8.03)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.14 (3.71)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Redundancy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">27.1 (26.9)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">20.6 (21.2)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">28.2 (26.2)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">16.3 (14.3)</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">
<bold>Structure</bold>
<break/>
<bold>determination</bold>
<break/>
<bold>Refinement</bold>
</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Resolution cut-off (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">34.50-<bold>3.25</bold></td>
              <td align="left" valign="top" rowspan="1" colspan="1">45.80-<bold>3.10</bold></td>
              <td align="left" valign="top" rowspan="1" colspan="1">20.00-<bold>3.32</bold></td>
              <td align="left" valign="top" rowspan="1" colspan="1">25.00-<bold>3.71</bold></td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">No. of Work / Test reflections</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9888/474</td>
              <td align="left" valign="top" rowspan="1" colspan="1">10725/528</td>
              <td align="left" valign="top" rowspan="1" colspan="1">9251/445</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6860/684</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1"><italic>R</italic><sub>crvst</sub> (%) /
<italic>R</italic><sub>free</sub> (%)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">216/23.5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">21.7/25.9</td>
              <td align="left" valign="top" rowspan="1" colspan="1">20.9/25.3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">22.7/25.4</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">No. of protein atoms</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3008</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2960</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2995</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3008</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">No. of
heteroatoms<break/><italic>B</italic> factors
(Ã)<sup>2</sup></td>
              <td align="left" valign="top" rowspan="1" colspan="1">42</td>
              <td align="left" valign="top" rowspan="1" colspan="1">42</td>
              <td align="left" valign="top" rowspan="1" colspan="1">10</td>
              <td align="left" valign="top" rowspan="1" colspan="1">62</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â Protein</td>
              <td align="left" valign="top" rowspan="1" colspan="1">126.2</td>
              <td align="left" valign="top" rowspan="1" colspan="1">111.8</td>
              <td align="left" valign="top" rowspan="1" colspan="1">137.0</td>
              <td align="left" valign="top" rowspan="1" colspan="1">135.5</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â Heteroatoms</td>
              <td align="left" valign="top" rowspan="1" colspan="1">123.5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">99.5</td>
              <td align="left" valign="top" rowspan="1" colspan="1">125.6</td>
              <td align="left" valign="top" rowspan="1" colspan="1">132.7</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">R.m.s. deviations from ideal</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â Bond
lengths (Ã)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.009</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.01</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.009</td>
              <td align="left" valign="top" rowspan="1" colspan="1">0.009</td>
            </tr>
            <tr>
              <td align="left" valign="top" rowspan="1" colspan="1">Â Â Â Â Bond
angles (Â°)</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.06</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.12</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.05</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1.03</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p id="P63">One crystal was used to collect diffraction datasets for each
structure, except in the EAAT1<sub>cryst</sub> UCPH<sub>101</sub> and
TFB-TBOA bound structure, where datasets from three crystals were
merged.</p>
            <p id="P64">5% of reflections were used for calculations of
<italic>R</italic><sub>free</sub>, except for the EAAT1cryst UCPH101-TBOATFB
bound structure where 10% was used due to the lower number of total reflections.</p>
          </fn>
          <fn id="TFN2">
            <label>*</label>
            <p id="P65">Values in parentheses are for the highest-resolution shell.</p>
          </fn>
          <fn id="TFN3">
            <label>$</label>
            <p id="P66">The anisotropy directions where computed with AIMLESS.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
  </body>
  <back>
    <ack id="S17">
      <title>Acknowledgements</title>
      <p>We thank Olga Boudker for comments on the manuscript and discussion on consensus
mutagenesis; Petya V. Krasteva for comments on the manuscript; Ahmed Haouz and the
staff at the crystallogenesis core facility of the Institut Pasteur for assistance
with crystallization screens; Staff at Synchrotron Soleil and the European
Synchrotron Radiation Facility for assistance with data collection; Darragh
OâBrien for discussion of HDX results. The work was funded by the ERC
Starting grant 309657 (N.R.). Further support from G5 Institut Pasteur funds (N.R.),
CACSICE grant (ANR-11-EQPX-008), and CNRS UMR3528 (N.R, J.C.-R.) is
acknowledged.</p>
    </ack>
    <fn-group>
      <fn fn-type="con" id="FN1">
        <p id="P67">
<bold>Author contribution</bold>
</p>
        <p id="P68">J.C.C.-T., and R.A. optimized and performed protein expression,
purification and crystallization, and R.A. performed molecular biology;
J.C.C.-T., R.A., and N.R. collected crystallographic data, and J.C.C.-T., P.L.,
and N.R. analyzed diffraction data and structures; E.C. and R.A performed and
analyzed uptake experiments; E.C. prepared protein samples for HDX-MS; S.B.
collected and analyzed HDX-MS data with help from E.C.; All authors contributed
to the experimental design of the project and manuscript preparation. N.R.
conceived and supervised the project.</p>
      </fn>
      <fn fn-type="COI-statement" id="FN2">
        <p id="P69"><bold>Author Information</bold> The authors declare no competing
financial interests.</p>
      </fn>
      <fn id="FN3">
        <p id="P70">
<bold>Data availability</bold>
</p>
        <p id="P71">Coordinates and structure factors for the
EAAT1<sub>cryst</sub>-UCPH<sub>101</sub>,
EAAT1cryst-UCPH<sub>101</sub>-TBOA<sub>TFB</sub>,
EAAT1<sub>cryst-II</sub>-UCPH<sub>101</sub>, and EAAT1<sub>cryst-II</sub>
crystal structures have been deposited in the Protein Data Bank with accession
codes 5LLM, 5MJU, 5LM4, 5LLU, respectively. All other data are available from
the corresponding author upon reasonable request.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Slotboom</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Konings</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Lolkema</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Structural features of the glutamate transporter
family</article-title>
          <source>Microbiol Mol Biol Rev</source>
          <year>1999</year>
          <volume>63</volume>
          <fpage>293</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">10357852</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hediger</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The glutamate and neutral amino acid transporter family:
physiological and pharmacological implications</article-title>
          <source>Eur J Pharmacol</source>
          <year>2003</year>
          <volume>479</volume>
          <fpage>237</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">14612154</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Danbolt</surname>
              <given-names>NC</given-names>
            </name>
          </person-group>
          <article-title>Glutamate uptake</article-title>
          <source>Prog Neurobiol</source>
          <year>2001</year>
          <volume>65</volume>
          <fpage>1</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">11369436</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehre</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Danbolt</surname>
              <given-names>NC</given-names>
            </name>
          </person-group>
          <article-title>The number of glutamate transporter subtype molecules at
glutamatergic synapses: chemical and stereological quantification in young
adult rat brain</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>8751</fpage>
          <lpage>8757</lpage>
          <pub-id pub-id-type="pmid">9786982</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zerangue</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kavanaugh</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Flux coupling in a neuronal glutamate transporter</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>383</volume>
          <fpage>634</fpage>
          <lpage>637</lpage>
          <pub-id pub-id-type="doi">10.1038/383634a0</pub-id>
          <pub-id pub-id-type="pmid">8857541</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rothstein</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Van Kammen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Levey</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Kuncl</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Selective loss of glial glutamate transporter GLT-1 in
amyotrophic lateral sclerosis</article-title>
          <source>Ann Neurol</source>
          <year>1995</year>
          <volume>38</volume>
          <fpage>73</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.410380114</pub-id>
          <pub-id pub-id-type="pmid">7611729</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Winter</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kovermann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fahlke</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A point mutation associated with episodic ataxia 6 increases
glutamate transporter anion currents</article-title>
          <source>Brain</source>
          <year>2012</year>
          <volume>135</volume>
          <fpage>3416</fpage>
          <lpage>3425</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/aws255</pub-id>
          <pub-id pub-id-type="pmid">23107647</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>KD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Late-onset episodic ataxia associated with SLC1A3
mutation</article-title>
          <source>J Hum Genet</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.1038/jhg.2016.137</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chao</surname>
              <given-names>XD</given-names>
            </name>
            <name>
              <surname>Fei</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fei</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>The role of excitatory amino acid transporters in cerebral
ischemia</article-title>
          <source>Neurochem Res</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>1224</fpage>
          <lpage>1230</lpage>
          <pub-id pub-id-type="doi">10.1007/s11064-010-0178-3</pub-id>
          <pub-id pub-id-type="pmid">20440555</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pilc</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wieronska</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Skolnick</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Glutamate-based antidepressants: preclinical
psychopharmacology</article-title>
          <source>Biol Psychiatry</source>
          <year>2013</year>
          <volume>73</volume>
          <fpage>1125</fpage>
          <lpage>1132</lpage>
          <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.01.021</pub-id>
          <pub-id pub-id-type="pmid">23453290</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robert</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sontheimer</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Glutamate transporters in the biology of malignant
gliomas</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2014</year>
          <volume>71</volume>
          <fpage>1839</fpage>
          <lpage>1854</lpage>
          <pub-id pub-id-type="doi">10.1007/s00018-013-1521-z</pub-id>
          <pub-id pub-id-type="pmid">24281762</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zerangue</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kavanaugh</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>ASCT-1 is a neutral amino acid exchanger with chloride channel
activity</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>27991</fpage>
          <lpage>27994</lpage>
          <pub-id pub-id-type="pmid">8910405</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeting glutamine transport to suppress melanoma cell
growth</article-title>
          <source>Int J Cancer</source>
          <year>2014</year>
          <volume>135</volume>
          <fpage>1060</fpage>
          <lpage>1071</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.28749</pub-id>
          <pub-id pub-id-type="pmid">24531984</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimizu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker
in non-small cell lung cancer</article-title>
          <source>Br J Cancer</source>
          <year>2014</year>
          <volume>110</volume>
          <fpage>2030</fpage>
          <lpage>2039</lpage>
          <pub-id pub-id-type="doi">10.1038/bjc.2014.88</pub-id>
          <pub-id pub-id-type="pmid">24603303</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeting ASCT2-mediated glutamine uptake blocks prostate cancer
growth and tumour development</article-title>
          <source>J Pathol</source>
          <year>2015</year>
          <volume>236</volume>
          <fpage>278</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="doi">10.1002/path.4518</pub-id>
          <pub-id pub-id-type="pmid">25693838</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Geldermalsen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ASCT2/SLC1A5 controls glutamine uptake and tumour growth in
triple-negative basal-like breast cancer</article-title>
          <source>Oncogene</source>
          <year>2016</year>
          <volume>35</volume>
          <fpage>3201</fpage>
          <lpage>3208</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2015.381</pub-id>
          <pub-id pub-id-type="pmid">26455325</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimamoto</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Glutamate transporter blockers for elucidation of the function of
excitatory neurotransmission systems</article-title>
          <source>Chem Rec</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>182</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="doi">10.1002/tcr.20145</pub-id>
          <pub-id pub-id-type="pmid">18563834</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grewer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grabsch</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>New inhibitors for the neutral amino acid transporter ASCT2
reveal its Na+-dependent anion leak</article-title>
          <source>J Physiol</source>
          <year>2004</year>
          <volume>557</volume>
          <fpage>747</fpage>
          <lpage>759</lpage>
          <pub-id pub-id-type="doi">10.1113/jphysiol.2004.062521</pub-id>
          <pub-id pub-id-type="pmid">15107471</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>AA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Discovery of the first selective inhibitor of excitatory amino
acid transporter subtype 1</article-title>
          <source>J Med Chem</source>
          <year>2009</year>
          <volume>52</volume>
          <fpage>912</fpage>
          <lpage>915</lpage>
          <pub-id pub-id-type="doi">10.1021/jm8013458</pub-id>
          <pub-id pub-id-type="pmid">19161278</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abrahamsen</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Allosteric modulation of an excitatory amino acid transporter:
the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of
EAAT1 through an intramonomeric site in the trimerization
domain</article-title>
          <source>J Neurosci</source>
          <year>2013</year>
          <volume>33</volume>
          <fpage>1068</fpage>
          <lpage>1087</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3396-12.2013</pub-id>
          <pub-id pub-id-type="pmid">23325245</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yernool</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Boudker</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gouaux</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Structure of a glutamate transporter homologue from Pyrococcus
horikoshii</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>431</volume>
          <fpage>811</fpage>
          <lpage>818</lpage>
          <pub-id pub-id-type="doi">10.1038/nature03018</pub-id>
          <pub-id pub-id-type="pmid">15483603</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reyes</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ginter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Boudker</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Transport mechanism of a bacterial homologue of glutamate
transporters</article-title>
          <source>Nature</source>
          <year>2009</year>
          <volume>462</volume>
          <fpage>880</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="doi">10.1038/nature08616</pub-id>
          <pub-id pub-id-type="pmid">19924125</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akyuz</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transport domain unlocking sets the uptake rate of an aspartate
transporter</article-title>
          <source>Nature</source>
          <year>2015</year>
          <volume>518</volume>
          <fpage>68</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1038/nature14158</pub-id>
          <pub-id pub-id-type="pmid">25652997</pub-id>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boudker</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Yernool</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shimamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gouaux</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Coupling substrate and ion binding to extracellular gate of a
sodium-dependent aspartate transporter</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>387</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05455</pub-id>
          <pub-id pub-id-type="pmid">17230192</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bendahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zarbiv</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kavanaugh</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Molecular determinant of ion selectivity of a (Na+ + K+)-coupled
rat brain glutamate transporter</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>751</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">9435265</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seal</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Amara</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>A reentrant loop domain in the glutamate carrier EAAT1
participates in substrate binding and translocation</article-title>
          <source>Neuron</source>
          <year>1998</year>
          <volume>21</volume>
          <fpage>1487</fpage>
          <lpage>1498</lpage>
          <pub-id pub-id-type="pmid">9883740</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tao</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanism of cation binding to the glutamate transporter EAAC1
probed with mutation of the conserved amino acid residue
Thr101</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>17725</fpage>
          <lpage>17733</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M110.121798</pub-id>
          <pub-id pub-id-type="pmid">20378543</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larsson</surname>
              <given-names>HP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence for a third sodium-binding site in glutamate
transporters suggests an ion/substrate coupling model</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>13912</fpage>
          <lpage>13917</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1006289107</pub-id>
          <pub-id pub-id-type="pmid">20634426</pub-id>
        </element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guskov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Faustino</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Marrink</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Slotboom</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Coupled binding mechanism of three sodium ions and aspartate in
the glutamate transporter homologue GltTk</article-title>
          <source>Nat Commun</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>13420</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms13420</pub-id>
          <pub-id pub-id-type="pmid">27830699</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crisman</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Forrest</surname>
              <given-names>LR</given-names>
            </name>
          </person-group>
          <article-title>Inward-facing conformation of glutamate transporters as revealed
by their inverted-topology structural repeats</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>20752</fpage>
          <lpage>20757</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0908570106</pub-id>
          <pub-id pub-id-type="pmid">19926849</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Focke</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Moenne-Loccoz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>HP</given-names>
            </name>
          </person-group>
          <article-title>Opposite movement of the external gate of a glutamate transporter
homolog upon binding cotransported sodium compared with
substrate</article-title>
          <source>J Neurosci</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>6255</fpage>
          <lpage>6262</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6096-10.2011</pub-id>
          <pub-id pub-id-type="pmid">21508248</pub-id>
        </element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brocke</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bendahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grunewald</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Proximity of two oppositely oriented reentrant loops in the
glutamate transporter GLT-1 identified by paired cysteine
mutagenesis</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>3985</fpage>
          <lpage>3992</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M107735200</pub-id>
          <pub-id pub-id-type="pmid">11724778</pub-id>
        </element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Substrates and non-transportable analogues induce structural
rearrangements at the extracellular entrance of the glial glutamate
transporter GLT-1/EAAT2</article-title>
          <source>J Biol Chem</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>26391</fpage>
          <lpage>26400</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M802401200</pub-id>
          <pub-id pub-id-type="pmid">18658151</pub-id>
        </element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seal</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Leighton</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Amara</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>A model for the topology of excitatory amino acid transporters
determined by the extracellular accessibility of substituted
cysteines</article-title>
          <source>Neuron</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>695</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">10774736</pub-id>
        </element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grunewald</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bendahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Biotinylation of single cysteine mutants of the glutamate
transporter GLT-1 from rat brain reveals its unusual
topology</article-title>
          <source>Neuron</source>
          <year>1998</year>
          <volume>21</volume>
          <fpage>623</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="pmid">9768848</pub-id>
        </element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Kortt</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Sirivanta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The position of an arginine residue influences substrate affinity
and K+ coupling in the human glutamate transporter, EAAT1</article-title>
          <source>J Neurochem</source>
          <year>2010</year>
          <volume>114</volume>
          <fpage>565</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06796.x</pub-id>
          <pub-id pub-id-type="pmid">20477940</pub-id>
        </element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borre</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Arginine 445 controls the coupling between glutamate and cations
in the neuronal transporter EAAC-1</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>2513</fpage>
          <lpage>2519</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M311446200</pub-id>
          <pub-id pub-id-type="pmid">14594797</pub-id>
        </element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bailey</surname>
              <given-names>CG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Loss-of-function mutations in the glutamate transporter SLC1A1
cause human dicarboxylic aminoaciduria</article-title>
          <source>J Clin Invest</source>
          <year>2011</year>
          <volume>121</volume>
          <fpage>446</fpage>
          <lpage>453</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI44474</pub-id>
          <pub-id pub-id-type="pmid">21123949</pub-id>
        </element-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leinenweber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Machtens</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Begemann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fahlke</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Regulation of glial glutamate transporters by C-terminal
domains</article-title>
          <source>J Biol Chem</source>
          <year>2011</year>
          <volume>286</volume>
          <fpage>1927</fpage>
          <lpage>1937</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M110.153486</pub-id>
          <pub-id pub-id-type="pmid">21097502</pub-id>
        </element-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shouffani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kanner</surname>
              <given-names>BI</given-names>
            </name>
          </person-group>
          <article-title>Cholesterol is required for the reconstruction of the sodium- and
chloride-coupled, gamma-aminobutyric acid transporter from rat
brain</article-title>
          <source>J Biol Chem</source>
          <year>1990</year>
          <volume>265</volume>
          <fpage>6002</fpage>
          <lpage>6008</lpage>
          <pub-id pub-id-type="pmid">2318845</pub-id>
        </element-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butchbach</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Association of excitatory amino acid transporters, especially
EAAT2, with cholesterol-rich lipid raft microdomains: importance for
excitatory amino acid transporter localization and function</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>34388</fpage>
          <lpage>34396</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M403938200</pub-id>
          <pub-id pub-id-type="pmid">15187084</pub-id>
        </element-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McIlwain</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Ryan</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Transport rates of a glutamate transporter homologue are
influenced by the lipid bilayer</article-title>
          <source>J Biol Chem</source>
          <year>2015</year>
          <volume>290</volume>
          <fpage>9780</fpage>
          <lpage>9788</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M114.630590</pub-id>
          <pub-id pub-id-type="pmid">25713135</pub-id>
        </element-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fairman</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Sonders</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Murdoch</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Amara</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Arachidonic acid elicits a substrate-gated proton current
associated with the glutamate transporter EAAT4</article-title>
          <source>Nat Neurosci</source>
          <year>1998</year>
          <volume>1</volume>
          <fpage>105</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="doi">10.1038/355</pub-id>
          <pub-id pub-id-type="pmid">10195124</pub-id>
        </element-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raunser</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Heterologously expressed GLT-1 associates in approximately 200-nm
protein-lipid islands</article-title>
          <source>Biophys J</source>
          <year>2006</year>
          <volume>91</volume>
          <fpage>3718</fpage>
          <lpage>3726</lpage>
          <pub-id pub-id-type="doi">10.1529/biophysj.106.086900</pub-id>
          <pub-id pub-id-type="pmid">16950847</pub-id>
        </element-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wales</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Engen</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen exchange mass spectrometry for the analysis of protein
dynamics</article-title>
          <source>Mass Spectrom Rev</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>158</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1002/mas.20064</pub-id>
          <pub-id pub-id-type="pmid">16208684</pub-id>
        </element-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konermann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YH</given-names>
            </name>
          </person-group>
          <article-title>Hydrogen exchange mass spectrometry for studying protein
structure and dynamics</article-title>
          <source>Chem Soc Rev</source>
          <year>2011</year>
          <volume>40</volume>
          <fpage>1224</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="doi">10.1039/c0cs00113a</pub-id>
          <pub-id pub-id-type="pmid">21173980</pub-id>
        </element-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimamoto</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of novel L-threo-beta-benzyloxyaspartate
derivatives, potent blockers of the glutamate transporters</article-title>
          <source>Mol Pharmacol</source>
          <year>2004</year>
          <volume>65</volume>
          <fpage>1008</fpage>
          <lpage>1015</lpage>
          <pub-id pub-id-type="doi">10.1124/mol.65.4.1008</pub-id>
          <pub-id pub-id-type="pmid">15044631</pub-id>
        </element-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watzke</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Grewer</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The anion conductance of the glutamate transporter EAAC1 depends
on the direction of glutamate transport</article-title>
          <source>FEBS Lett</source>
          <year>2001</year>
          <volume>503</volume>
          <fpage>121</fpage>
          <lpage>125</lpage>
          <pub-id pub-id-type="pmid">11513867</pub-id>
        </element-citation>
      </ref>
      <ref id="R49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reyes</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boudker</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Binding thermodynamics of a glutamate transporter
homolog</article-title>
          <source>Nat Struct Mol Biol</source>
          <year>2013</year>
          <volume>20</volume>
          <fpage>634</fpage>
          <lpage>640</lpage>
          <pub-id pub-id-type="doi">10.1038/nsmb.2548</pub-id>
          <pub-id pub-id-type="pmid">23563139</pub-id>
        </element-citation>
      </ref>
      <ref id="R50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawate</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gouaux</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Fluorescence-detection size-exclusion chromatography for
precrystallization screening of integral membrane proteins</article-title>
          <source>Structure</source>
          <year>2006</year>
          <volume>14</volume>
          <fpage>673</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="doi">10.1016/j.str.2006.01.013</pub-id>
          <pub-id pub-id-type="pmid">16615909</pub-id>
        </element-citation>
      </ref>
      <ref id="R51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steipe</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Schiller</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pluckthun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Steinbacher</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Sequence statistics reliably predict stabilizing mutations in a
protein domain</article-title>
          <source>J Mol Biol</source>
          <year>1994</year>
          <volume>240</volume>
          <fpage>188</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.1994.1434</pub-id>
          <pub-id pub-id-type="pmid">8028003</pub-id>
        </element-citation>
      </ref>
      <ref id="R52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabsch</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Xds</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>125</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id>
          <pub-id pub-id-type="pmid">20124692</pub-id>
        </element-citation>
      </ref>
      <ref id="R53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Murshudov</surname>
              <given-names>GN</given-names>
            </name>
          </person-group>
          <article-title>How good are my data and what is the resolution?</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2013</year>
          <volume>69</volume>
          <fpage>1204</fpage>
          <lpage>1214</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444913000061</pub-id>
          <pub-id pub-id-type="pmid">23793146</pub-id>
        </element-citation>
      </ref>
      <ref id="R54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCoy</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phaser crystallographic software</article-title>
          <source>J Appl Crystallogr</source>
          <year>2007</year>
          <volume>40</volume>
          <fpage>658</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id>
          <pub-id pub-id-type="pmid">19461840</pub-id>
        </element-citation>
      </ref>
      <ref id="R55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emsley</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lohkamp</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Cowtan</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Features and development of Coot</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>486</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>
          <pub-id pub-id-type="pmid">20383002</pub-id>
        </element-citation>
      </ref>
      <ref id="R56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blanc</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Refinement of severely incomplete structures with maximum
likelihood in BUSTER-TNT</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2004</year>
          <volume>60</volume>
          <fpage>2210</fpage>
          <lpage>2221</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444904016427</pub-id>
          <pub-id pub-id-type="pmid">15572774</pub-id>
        </element-citation>
      </ref>
      <ref id="R57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>DP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Structural models of intrinsically disordered and calcium-bound
folded states of a protein adapted for secretion</article-title>
          <source>Sci Rep</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>14223</fpage>
          <pub-id pub-id-type="doi">10.1038/srep14223</pub-id>
          <pub-id pub-id-type="pmid">26374675</pub-id>
        </element-citation>
      </ref>
      <ref id="R58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hourdel</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MEMHDX: An interactive tool to expedite the statistical
validation and visualization of large HDX-MS datasets</article-title>
          <source>Bioinformatics</source>
          <year>2016</year>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btw420</pub-id>
        </element-citation>
      </ref>
      <ref id="R59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waterhouse</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Procter</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Clamp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Jalview Version 2--a multiple sequence alignment editor and
analysis workbench</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>1189</fpage>
          <lpage>1191</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id>
          <pub-id pub-id-type="pmid">19151095</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Function and architecture of EAAT1<sub>cryst</sub>.</title>
        <p><bold>a-b</bold>, Uptake of radioactive L-glutamate by purified EAAT1 (grey),
EAAT1<sub>cryst</sub> (blue), and EAAT1<sub>cryst-II</sub> (red)
reconstituted in liposomes. Transport was abolished when choline
(Ch<sup>+</sup>) was used in the extra- or intra-liposomal solutions (yellow
circles) (<bold>a</bold>). UCPH<sub>101</sub> inhibits glutamate transport in a
concentration dependent manner (<bold>b</bold>). Plots depict an average of
three independent experiments performed with duplicate measurements, and error
bars represent s.e.m. <bold>c-d</bold>, Structure of EAAT1<sub>cryst</sub>
trimer viewed from the extracellular solution (<bold>c</bold>) and from the
membrane (<bold>d</bold>) highlighting the ScaD (teal) and TranD (orange).
<bold>e</bold>, EAAT1<sub>cryst</sub> monomer viewed parallel to the
membrane. The ScaD domain is represented as surface (teal), and several helices
and loops in the TranD (orange) have been removed. <bold>f</bold>, Domain
organization diagram of EAAT1<sub>cryst</sub> monomer.</p>
      </caption>
      <graphic xlink:href="emss-71849-f001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Transport domain.</title>
        <p>EAAT1<sub>cryst</sub> TranD with substrate (spheres) and one sodium ion (purple
spheres) bound. Omit Fo-Fc densities contoured at 2.3 Ï (black mesh) show
the position of the ligands. TM8a-c (blue) interacts with other regions on the
TranD (orange), including HP1 (left inset), HP2 (upper right inset), and TM3 and
TM7 (lower right inset).</p>
      </caption>
      <graphic xlink:href="emss-71849-f002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Scaffold domain.</title>
        <p><bold>a,</bold> TM4 (purple) makes extensive contacts with the ScaD of the
neighboring monomer (monomer 2, teal surface), and the TranD (orange) of the
same subunit (monomer 1). The TranD of monomer 2, and several TMs of monomer 1
were removed for clarity of display. Fo-Fc density in the HP2-TM4 crevice is
contoured at 2.7Ï (red mesh). <bold>b</bold>, Two monomers of
EAAT<sub>cryst</sub> show TM1a laying parallel to the membrane. The third
monomer is not shown. TM1 (teal) and HP1a (dark blue) form a hydrophobic crevice
containing non-protein Fo-Fc density (purple mesh, contour 2.7Ï).</p>
      </caption>
      <graphic xlink:href="emss-71849-f003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <title>UCPH<sub>101</sub> binding site.</title>
        <p><bold>a</bold>, Lateral view of EAAT1<sub>cryst</sub> monomer showing
UCPH<sub>101</sub> bound (pink) between the TranD (orange) and ScaD (teal).
<bold>b-c</bold>, UCPH<sub>101</sub> coordination and Fo-Fc densities
contoured at 2.0Ï (blue mesh) in EAAT1<sub>cryst</sub> (<bold>b</bold>)
and EAAT1<sub>cryst-II</sub> (<bold>c</bold>), respectively. Side chains of
residues in TM3, TM4c, and TM7 involved in coordination are shown. F369 side
chain moves outward in the EAAT1<sub>cryst-II</sub> unbound state (grey)
(<bold>c</bold>).</p>
      </caption>
      <graphic xlink:href="emss-71849-f004"/>
    </fig>
    <fig id="F5" orientation="portrait" position="float">
      <label>Figure 5</label>
      <caption>
        <title>Transport domain dynamics.</title>
        <p><bold>a,</bold> UCPH<sub>101</sub> decreased deuterium uptake in several regions
(black) of the TranD at the interface with the ScaD. The alpha carbon atoms
delimiting such regions are shown as black spheres. Unaffected regions of the
TranD (orange) or those not detected during HDX-MS analysis (grey) are also
highlighted (sequence coverage ~77%). <bold>b</bold>, TranD residues
buried at the interface with the ScaD, in the UPCH<sub>101</sub>-bound
outward-facing state, are colored dark blue for comparison with
(<bold>a</bold>). <bold>c-d,</bold> Comparison between EAAT1<sub>cryst</sub>
structure in the UPCH<sub>101</sub>-bound outward-facing state (<bold>c</bold>)
and a model of an inward-facing state based on the GltPh
âunlockedâ state (PDB 4X2S) (<bold>d</bold>), in which the TranD
(color code as in <bold>a</bold>) undergoes a large rigid body movement towards
the cytoplasm.</p>
      </caption>
      <graphic xlink:href="emss-71849-f005"/>
    </fig>
    <fig id="F6" orientation="portrait" position="float">
      <label>Figure 6</label>
      <caption>
        <title>UCPH<sub>101</sub>-TBOA<sub>TFB</sub> bound EAAT1<sub>cryst</sub>
structure.</title>
        <p><bold>a,</bold> The movement of HP2 (purple) partly exposes the substrate-binding
pocket to the solvent and shows a molecule of TBOA<sub>TFB</sub> (purple sticks)
bound to it. UCPH<sub>101</sub> is also observed in this structure (pink
sticks). <bold>b</bold>, The tip of HP2 moves as much as 9.5 Ã in the
UCPH<sub>101</sub>-TBOA<sub>TFB</sub>- (purple), compared to the
UCPH<sub>101</sub>-substrate bound (orange) structures, placing the carbonyl
oxygen of A420 away from Na2 (green sphere). <bold>c</bold>, Omit map Fo-Fc
density for the TBOA<sub>TFB</sub> molecule is contoured at 2.3Ï (black
mesh), and some of the residues at Van deer Waals or H-bond distance from the
compound are represented as sticks.</p>
      </caption>
      <graphic xlink:href="emss-71849-f006"/>
    </fig>
    <fig id="F7" orientation="portrait" position="float">
      <label>Figure 7</label>
      <caption>
        <title>EAAT1 inhibitory mechanisms.</title>
        <p>Schematic representation of TBOA-like competitive and UCPH<sub>101</sub>-like
allosteric inhibition. Competitive inhibitors, occupy the substrate-binding
pocket and preclude substrate binding. UCPH<sub>101</sub>-like compounds bind at
the TranD-ScaD interface and block the movement of the TranD (orange) relative
to the ScaD (teal).</p>
      </caption>
      <graphic xlink:href="emss-71849-f007"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>